The size of the OTC Orthopedic Braces Market in the Asia Pacific region was valued at USD 305.37 Million in 2022 at a CAGR of 5.3%, to reach USD 395.34 Million by 2027.
The market is showcasing substantial growth potential in the forecasting period and is also estimated to grow in the future years owing to the developments in the medical sector.
Orthopedic braces, also known as orthopedic splints, facilitate the protection, stabilization, and correction of injuries or abnormal structures. They are used for different applications like injury rehabilitation, prevention, and more. The braces are also designed in a way to compensate for muscles which have less strength in them. They rectify the structural anomalies and help in the detection of cerebral palsy, spina bifida, as well as to treat the symptoms of a stroke.
Many different factors like increasing middle-class population, growth of GDP, increased spending on healthcare and rising awareness among the public about different treatment options for orthopedic conditions are triggering the growth of the OTC orthopedic braces market in the Asia-Pacific region.
This research report on the Asia Pacific OTC Orthopedic Braces Market has been segmented and sub-segmented into the following categories.
Regionally, China and India are developing countries and are expected to lead the market because of emerging economies and the growing geriatric population.
Prominent companies leading the APAC OTC Orthopedic Braces Market are DJO Finance LLC, DeRoyal Industries Inc., Breg, Inc., Bauerfeind AG, BSN Medical, Otto Bock HealthCare, Medi GmbH & Co. KG, Thuasne Group, and 3M Company.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org